Concord Drugs standalone net profit rises 183.33% in the March 2021 quarter

Sales decline 35.92% to Rs 8.35 crore

Net profit of Concord Drugs rose 183.33% to Rs 0.34 crore in the quarter ended March 2021 as against Rs 0.12 crore during the previous quarter ended March 2020. Sales declined 35.92% to Rs 8.35 crore in the quarter ended March 2021 as against Rs 13.03 crore during the previous quarter ended March 2020.

For the full year,net profit rose 893.94% to Rs 3.28 crore in the year ended March 2021 as against Rs 0.33 crore during the previous year ended March 2020. Sales rose 0.04% to Rs 51.36 crore in the year ended March 2021 as against Rs 51.34 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales8.3513.03 -36 51.3651.34 0 OPM %8.625.60 -6.276.51 - PBDT0.470.51 -8 1.901.92 -1 PBT0.140.15 -7 0.530.46 15 NP0.340.12 183 3.280.33 894

Powered by Capital Market - Live News